Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Methylamine Activates Glucose Uptake in Human Adipocytes Without Overpassing Action of Insulin or Stimulating its Secretion in Pancreatic Islets.

Carpéné C, Mauriège P, Boulet N, Biron S, Grolleau JL, Garcia-Barrado MJ, Iglesias-Osma MC.

Medicines (Basel). 2019 Aug 12;6(3). pii: E89. doi: 10.3390/medicines6030089.

2.

Oral Phenelzine Treatment Mitigates Metabolic Disturbances in Mice Fed a High-Fat Diet.

Mercader J, Sabater A, Le Gonidec S, Decaunes P, Chaplin A, Gomez-Zorita S, Milagro F, Carpene C.

J Pharmacol Exp Ther. 2019 Jul 3. pii: jpet.119.259895. doi: 10.1124/jpet.119.259895. [Epub ahead of print]

3.

Effects of the amino acid derivatives, β-hydroxy-β-methylbutyrate, taurine, and N-methyltyramine, on triacylglycerol breakdown in fat cells.

Leroux M, Lemery T, Boulet N, Briot A, Zakaroff A, Bouloumié A, Andrade F, Pérez-Matute P, Arbones-Mainar JM, Carpéné C.

J Physiol Biochem. 2019 Mar 27. doi: 10.1007/s13105-019-00677-5. [Epub ahead of print]

PMID:
30919256
4.

Resveratrol Anti-Obesity Effects: Rapid Inhibition of Adipocyte Glucose Utilization.

Carpéné C, Les F, Cásedas G, Peiro C, Fontaine J, Chaplin A, Mercader J, López V.

Antioxidants (Basel). 2019 Mar 26;8(3). pii: E74. doi: 10.3390/antiox8030074.

5.

Past, Present and Future Anti-Obesity Effects of Flavin-Containing and/or Copper-Containing Amine Oxidase Inhibitors.

Carpéné C, Boulet N, Chaplin A, Mercader J.

Medicines (Basel). 2019 Jan 15;6(1). pii: E9. doi: 10.3390/medicines6010009. Review.

6.

Regulation of glucose metabolism by bioactive phytochemicals for the management of type 2 diabetes mellitus.

Zhao C, Yang C, Wai STC, Zhang Y, P Portillo M, Paoli P, Wu Y, San Cheang W, Liu B, Carpéné C, Xiao J, Cao H.

Crit Rev Food Sci Nutr. 2019;59(6):830-847. doi: 10.1080/10408398.2018.1501658. Epub 2018 Dec 3.

PMID:
30501400
7.

Resveratrol, Metabolic Syndrome, and Gut Microbiota.

Chaplin A, Carpéné C, Mercader J.

Nutrients. 2018 Nov 3;10(11). pii: E1651. doi: 10.3390/nu10111651. Review.

8.

Metabolic Effects of Oral Phenelzine Treatment on High-Sucrose-Drinking Mice.

Carpéné C, Gómez-Zorita S, Chaplin A, Mercader J.

Int J Mol Sci. 2018 Sep 25;19(10). pii: E2904. doi: 10.3390/ijms19102904.

9.

Mechanisms of the antilipolytic response of human adipocytes to tyramine, a trace amine present in food.

Carpéné C, Galitzky J, Belles C, Zakaroff-Girard A.

J Physiol Biochem. 2018 Nov;74(4):623-633. doi: 10.1007/s13105-018-0643-z. Epub 2018 Jul 23.

PMID:
30039351
10.

The Dietary Antioxidant Piceatannol Inhibits Adipogenesis of Human Adipose Mesenchymal Stem Cells and Limits Glucose Transport and Lipogenic Activities in Adipocytes.

Carpéné C, Pejenaute H, Del Moral R, Boulet N, Hijona E, Andrade F, Villanueva-Millán MJ, Aguirre L, Arbones-Mainar JM.

Int J Mol Sci. 2018 Jul 17;19(7). pii: E2081. doi: 10.3390/ijms19072081.

11.

Body fat reduction without cardiovascular changes in mice after oral treatment with the MAO inhibitor phenelzine.

Carpéné C, Mercader J, Le Gonidec S, Schaak S, Mialet-Perez J, Zakaroff-Girard A, Galitzky J.

Br J Pharmacol. 2018 Jun;175(12):2428-2440. doi: 10.1111/bph.14211. Epub 2018 May 6.

12.

Short-term effects of obestatin on hexose uptake and triacylglycerol breakdown in human subcutaneous adipocytes.

Carpéné C, Les F, Estève D, Galitzky J.

World J Diabetes. 2018 Jan 15;9(1):25-32. doi: 10.4239/wjd.v9.i1.25.

13.

Natriuretic peptides promote glucose uptake in a cGMP-dependent manner in human adipocytes.

Coué M, Barquissau V, Morigny P, Louche K, Lefort C, Mairal A, Carpéné C, Viguerie N, Arner P, Langin D, Rydén M, Moro C.

Sci Rep. 2018 Jan 18;8(1):1097. doi: 10.1038/s41598-018-19619-0.

14.

Pterostilbene Inhibits Lipogenic Activity similar to Resveratrol or Caffeine but Differently Modulates Lipolysis in Adipocytes.

Gomez-Zorita S, Belles C, Briot A, Fernández-Quintela A, Portillo MP, Carpéné C.

Phytother Res. 2017 Aug;31(8):1273-1282. doi: 10.1002/ptr.5852. Epub 2017 Jun 19.

PMID:
28627722
15.

Insulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cells.

Carpéné C, Garcia-Vicente S, Serrano M, Marti L, Belles C, Royo M, Galitzky J, Zorzano A, Testar X.

World J Diabetes. 2017 Apr 15;8(4):143-153. doi: 10.4239/wjd.v8.i4.143.

16.

Anti-obesity effects of resveratrol: comparison between animal models and humans.

Fernández-Quintela A, Carpéné C, Fernández M, Aguirre L, Milton-Laskibar I, Contreras J, Portillo MP.

J Physiol Biochem. 2016 Aug;73(3):417-429. doi: 10.1007/s13105-016-0544-y. Epub 2016 Dec 15. Review. Erratum in: J Physiol Biochem. 2017 Oct 5;:.

PMID:
27981508
17.

Anatomical distribution of primary amine oxidase activity in four adipose depots and plasma of severely obese women with or without a dysmetabolic profile.

Carpéné C, Les F, Hasnaoui M, Biron S, Marceau P, Richard D, Galitzky J, Joanisse DR, Mauriège P.

J Physiol Biochem. 2016 Aug;73(3):475-486. doi: 10.1007/s13105-016-0526-0. Epub 2016 Oct 21. Erratum in: J Physiol Biochem. 2017 Oct 5;:.

PMID:
27766585
18.

Advances in Integrating Traditional and Omic Biomarkers When Analyzing the Effects of the Mediterranean Diet Intervention in Cardiovascular Prevention.

Fitó M, Melander O, Martínez JA, Toledo E, Carpéné C, Corella D.

Int J Mol Sci. 2016 Sep 2;17(9). pii: E1469. doi: 10.3390/ijms17091469. Review.

19.

Piceatannol and resveratrol share inhibitory effects on hydrogen peroxide release, monoamine oxidase and lipogenic activities in adipose tissue, but differ in their antilipolytic properties.

Les F, Deleruyelle S, Cassagnes LE, Boutin JA, Balogh B, Arbones-Mainar JM, Biron S, Marceau P, Richard D, Nepveu F, Mauriège P, Carpéné C.

Chem Biol Interact. 2016 Oct 25;258:115-25. doi: 10.1016/j.cbi.2016.07.014. Epub 2016 Jul 28.

PMID:
27475863
20.

Dietary Phenolic Compounds Interfere with the Fate of Hydrogen Peroxide in Human Adipose Tissue but Do Not Directly Inhibit Primary Amine Oxidase Activity.

Carpéné C, Hasnaoui M, Balogh B, Matyus P, Fernández-Quintela A, Rodríguez V, Mercader J, Portillo MP.

Oxid Med Cell Longev. 2016;2016:2427618. doi: 10.1155/2016/2427618. Epub 2016 Jan 5.

21.

Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects.

Hijona E, Aguirre L, Pérez-Matute P, Villanueva-Millán MJ, Mosqueda-Solis A, Hasnaoui M, Nepveu F, Senard JM, Bujanda L, Aldámiz-Echevarría L, Llarena M, Andrade F, Perio P, Leboulanger F, Hijona L, Arbones-Mainar JM, Portillo MP, Carpéné C.

J Physiol Biochem. 2016 Sep;72(3):567-82. doi: 10.1007/s13105-015-0464-2. Epub 2016 Jan 20.

PMID:
26792656
22.

Potential renoprotective effects of piceatannol in ameliorating the early-stage nephropathy associated with obesity in obese Zucker rats.

Llarena M, Andrade F, Hasnaoui M, Portillo MP, Pérez-Matute P, Arbones-Mainar JM, Hijona E, Villanueva-Millán MJ, Aguirre L, Carpéné C, Aldámiz-Echevarría L.

J Physiol Biochem. 2016 Sep;72(3):555-66. doi: 10.1007/s13105-015-0457-1. Epub 2015 Dec 10.

PMID:
26660756
23.

High intake of dietary tyramine does not deteriorate glucose handling and does not cause adverse cardiovascular effects in mice.

Carpéné C, Schaak S, Guilbeau-Frugier C, Mercader J, Mialet-Perez J.

J Physiol Biochem. 2016 Sep;72(3):539-53. doi: 10.1007/s13105-015-0456-2. Epub 2015 Dec 3.

PMID:
26634369
24.

Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.

Carpéné C, Bizou M, Tréguer K, Hasnaoui M, Grès S.

J Physiol Biochem. 2015 Sep;71(3):487-96. doi: 10.1007/s13105-014-0379-3. Epub 2015 Jan 9.

PMID:
25572340
25.

Novel strategies for preventing diabetes and obesity complications with natural polyphenols.

Carpene C, Gomez-Zorita S, Deleruyelle S, Carpene MA.

Curr Med Chem. 2015;22(1):150-64. Review.

PMID:
25139462
26.

Combination of low dose of the anti-adipogenic agents resveratrol and phenelzine in drinking water is not sufficient to prevent obesity in very-high-fat diet-fed mice.

Carpéné C, Gomez-Zorita S, Gupta R, Grès S, Rancoule C, Cadoudal T, Mercader J, Gomez A, Bertrand C, Iffiu-Soltész Z.

Eur J Nutr. 2014 Dec;53(8):1625-35. doi: 10.1007/s00394-014-0668-1. Epub 2014 Feb 15.

PMID:
24531732
27.

Is there an optimal dose for dietary linoleic acid? Lessons from essential fatty acid deficiency supplementation and adipocyte functions in rats.

Harant-Farrugia I, Garcia J, Iglesias-Osma MC, Garcia-Barrado MJ, Carpéné C.

J Physiol Biochem. 2014 Jun;70(2):615-27. doi: 10.1007/s13105-014-0315-6. Epub 2014 Feb 1.

PMID:
24488489
28.

Special Issue: 15th amine oxidase conference: re-examine the amines.

Carpéné C, Parini A.

J Neural Transm (Vienna). 2013 Jun;120(6):845-6. doi: 10.1007/s00702-013-1022-0. No abstract available.

PMID:
23563848
29.

Oxidation of high doses of serotonin favors lipid accumulation in mouse and human fat cells.

Grès S, Canteiro S, Mercader J, Carpéné C.

Mol Nutr Food Res. 2013 Jun;57(6):1089-99. doi: 10.1002/mnfr.201200681. Epub 2013 Feb 6.

PMID:
23390020
30.

Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells.

Gomez-Zorita S, Tréguer K, Mercader J, Carpéné C.

J Physiol Biochem. 2013 Sep;69(3):585-93. doi: 10.1007/s13105-012-0229-0. Epub 2013 Jan 13.

PMID:
23315205
31.

5-hydroxytryptamine actions in adipocytes: involvement of monoamine oxidase-dependent oxidation and subsequent PPARγ activation.

Grès S, Gomez-Zorita S, Gomez-Ruiz A, Carpéné C.

J Neural Transm (Vienna). 2013 Jun;120(6):919-26. doi: 10.1007/s00702-012-0959-8. Epub 2012 Dec 28.

PMID:
23271029
32.

The amine oxidase inhibitor phenelzine limits lipogenesis in adipocytes without inhibiting insulin action on glucose uptake.

Carpéné C, Grès S, Rascalou S.

J Neural Transm (Vienna). 2013 Jun;120(6):997-1003. doi: 10.1007/s00702-012-0951-3. Epub 2012 Dec 16.

PMID:
23242743
33.

Benzylamine antihyperglycemic effect is abolished by AOC3 gene invalidation in mice but not rescued by semicarbazide-sensitive amine oxidase expression under the control of aP2 promoter.

Grès S, Bour S, Valet P, Carpéné C.

J Physiol Biochem. 2012 Dec;68(4):651-62. doi: 10.1007/s13105-012-0171-1. Epub 2012 May 1.

PMID:
22547093
34.

Long-term activation of semicarbazide-sensitive amine oxidase lowers circulating levels of uric acid in diabetic conditions.

Carpéné C, Desquesnes A, Gomez-Ruiz A, Iffiú-Soltész Z, Le Gonidec S, Mercader J.

Physiol Res. 2012;61(3):251-7. Epub 2012 Apr 5.

35.

SSAO substrates exhibiting insulin-like effects in adipocytes as a promising treatment option for metabolic disorders.

Mercader J, Iffiú-Soltesz Z, Brenachot X, Földi A, Dunkel P, Balogh B, Attané C, Valet P, Mátyus P, Carpéné C.

Future Med Chem. 2010 Dec;2(12):1735-49. doi: 10.4155/fmc.10.260.

PMID:
21428797
36.

Isopropylnorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium.

Mercader J, Wanecq E, Chen J, Carpéné C.

J Physiol Biochem. 2011 Sep;67(3):443-52. doi: 10.1007/s13105-011-0078-2. Epub 2011 Feb 19.

PMID:
21336650
37.

Oral Administration of Semicarbazide Limits Weight Gain together with Inhibition of Fat Deposition and of Primary Amine Oxidase Activity in Adipose Tissue.

Mercader J, Iffiú-Soltész Z, Bour S, Carpéné C.

J Obes. 2011;2011:475786. doi: 10.1155/2011/475786. Epub 2011 Feb 8.

38.

Increased primary amine oxidase expression and activity in white adipose tissue of obese and diabetic db-/- mice.

Iffiú-Soltész Z, Mercader J, Daviaud D, Boucher J, Carpéné C.

J Neural Transm (Vienna). 2011 Jul;118(7):1071-7. doi: 10.1007/s00702-011-0586-9. Epub 2011 Feb 5.

PMID:
21298297
39.

Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo.

Attané C, Daviaud D, Dray C, Dusaulcy R, Masseboeuf M, Prévot D, Carpéné C, Castan-Laurell I, Valet P.

J Mol Endocrinol. 2011 Jan 19;46(1):21-8. doi: 10.1677/JME-10-0105. Print 2011 Feb.

PMID:
21062936
40.

Adipose tissue lymphocytes: types and roles.

Caspar-Bauguil S, Cousin B, Bour S, Casteilla L, Penicaud L, Carpéné C.

J Physiol Biochem. 2009 Dec;65(4):423-36. doi: 10.1007/BF03185938. Review. Erratum in: J Physiol Biochem. 2011 Sep;67(3):497. Castiella, L [corrected to Casteilla, L].

PMID:
20358356
41.

Possible mechanisms of weight loss of Siberian hamsters (Phodopus sungorus sungorus) exposed to short photoperiod.

Atgié C, Sauvant P, Ambid L, Carpéné C.

J Physiol Biochem. 2009 Dec;65(4):377-86. doi: 10.1007/BF03185933.

PMID:
20358351
42.

Lack of direct insulin-like action of visfatin/Nampt/PBEF1 in human adipocytes.

Wanecq E, Prévot D, Carpéné C.

J Physiol Biochem. 2009 Dec;65(4):351-9. doi: 10.1007/BF03185930.

PMID:
20358348
43.

Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice.

Iffiú-Soltész Z, Wanecq E, Lomba A, Portillo MP, Pellati F, Szöko E, Bour S, Woodley J, Milagro FI, Alfredo Martinez J, Valet P, Carpéné C.

Pharmacol Res. 2010 Apr;61(4):355-63. doi: 10.1016/j.phrs.2009.12.014. Epub 2010 Jan 4.

PMID:
20045461
44.

Histamine oxidation in mouse adipose tissue is controlled by the AOC3 gene-encoded amine oxidase.

Iffiú-Soltész Z, Wanecq E, Prévot D, Grès S, Carpéné C.

Inflamm Res. 2010 Mar;59 Suppl 2:S227-9. doi: 10.1007/s00011-009-0129-0.

PMID:
20012150
45.
46.

Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 deficiency reduces leukocyte infiltration into adipose tissue and favors fat deposition.

Bour S, Caspar-Bauguil S, Iffiú-Soltész Z, Nibbelink M, Cousin B, Miiluniemi M, Salmi M, Stolen C, Jalkanen S, Casteilla L, Pénicaud L, Valet P, Carpéné C.

Am J Pathol. 2009 Mar;174(3):1075-83. doi: 10.2353/ajpath.2009.080612. Epub 2009 Feb 13.

47.

Antidepressant phenelzine alters differentiation of cultured human and mouse preadipocytes.

Chiche F, Le Guillou M, Chétrite G, Lasnier F, Dugail I, Carpéné C, Moldes M, Fève B.

Mol Pharmacol. 2009 May;75(5):1052-61. doi: 10.1124/mol.108.052563. Epub 2009 Feb 6.

PMID:
19201819
48.

Apelin stimulates glucose utilization in normal and obese insulin-resistant mice.

Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buléon M, Cani PD, Attané C, Guigné C, Carpéné C, Burcelin R, Castan-Laurell I, Valet P.

Cell Metab. 2008 Nov;8(5):437-45. doi: 10.1016/j.cmet.2008.10.003.

49.

Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.

Carpéné C, Abello V, Iffiú-Soltész Z, Mercier N, Fève B, Valet P.

Pharmacol Res. 2008 Jun;57(6):426-34. doi: 10.1016/j.phrs.2008.04.005. Epub 2008 Apr 24.

PMID:
18539478
50.

Expanding role for the apelin/APJ system in physiopathology.

Carpéné C, Dray C, Attané C, Valet P, Portillo MP, Churruca I, Milagro FI, Castan-Laurell I.

J Physiol Biochem. 2007 Dec;63(4):359-73. Review.

PMID:
18457011

Supplemental Content

Loading ...
Support Center